No analyst coverage available for this stock.
ChemoMetec A/S is a Denmark-based company specializing in the development, manufacture, and sale of analytical instruments for precise cell counting and analysis in liquids. Its core technology integrates fluorescence microscopy with digital imagery to deliver consistent, reproducible results, eliminating human error through disposable, pre-filled cassettes like Via1-Cassette™ and Via2-Cassette™. Key products include the NucleoCounter® series—such as NC-3000™, an advanced image cytometer; NC-250 and NC-202 for automated cell counting; and SP-100 for sperm analysis—as well as XcytoMatic® 30 and 40 analyzers for high-throughput bioprocessing up to 100 million cells/ml. The company also offers consumables like reagents and slides, plus services including validation and training. Serving biotech, pharmaceutical, academic, food processing, and agriculture sectors globally, particularly in cell and gene therapy, cancer research, stem cell studies, and quality control for animal semen, milk, and beer, ChemoMetec A/S supports GMP and 21 CFR Part 11-compliant environments. Founded in 1997 and headquartered in Allerød, Denmark, it operates through instruments, consumables, and partnership segments, catering to an international clientele with dedicated support.